Stock Earnings Short interest on ADAP sees a significant decrease on 2025-07-15 The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Taking a Closer Look At Adaptimmune Therapeutics Plc ADR (ADAP) Following Its Recent Trade Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Medical Officer Norry Elliot unloaded Company’s shares for reported $3243.0